Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Daniela Rivero Yeverino, MD"'
Aeroallergen immunotherapy associated with reduced risk of severe COVID-19 in 1095 allergic patients
Autor:
Désirée Larenas-Linnemann, MD, Blanca María Morfin-Maciel, MD, Martín Bedolla-Barajas, MD, MSc, Ana López-Bago, MD, Elsy Maureen Navarrete Rodríguez, MD, MSc, María Dolores Mogica-Martínez, MD, José E. Gereda, MD, Mauricio Sarrazola Sanjuan, MD, MSc, Rosa Yazmín Cano Pedroza, MD, María Cecilia Cavallo, MD, Sergio de Jesús Romero Tapia, MD, Roberto A. Jossen, MD, José Miguel Fuentes Pérez, MD, Blanca E. Del Rio Navarro, MD, Erendira Rodríguez Zagal, MD, Pedro A. Piraino Sosa, MD, Yunuen Rocío Huerta Villalobos, MD, Pierre Chavez-Vereau, MD, Daniel Alberto García Imperial, MD, Margarita Olivares Gómez, MD, Francisco Valle Rodríguez, MD, Carlos Omar Zuñiga Reyes, MD, Mónica Rodríguez-González, MD, Claudia Ivonne Gallego Corella, MD, Juan Carlos Ivancevich, MD, María de la Luz Hortencia García Cruz, MD, María Susana Repka-Ramirez, MD, Mauricio Ernesto Flores Morales, MD, Juan Carlos Fernández De Córdova Aguirre, MD, MSc, Jorge A. Luna-Pech, MD, PhD, Daniela Rivero Yeverino, MD, Edgar Martínez Guzmán, MD, Cinthia Elizabeth Pérez Ortiz, MD, Leonor Villa Médica, MD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 5, Pp 100779- (2023)
Introduction: Allergen immunotherapy (AIT) brings along changes in the immune system, restoring dendritic cell function, reducing T2 inflammation and augmenting the regulatory cell activation. Coronavirus disease (COVID-19), caused by severe acute re
Externí odkaz:
https://doaj.org/article/cd7960e0d97546b88f333cb19e028f58
Autor:
Bernardo Sousa-Pinto, PhD, Cristina Jácome, PhD, Ana Margarida Pereira, MD, Frederico S Regateiro, MD, Rute Almeida, PhD, Wienczyslawa Czarlewski, MD, Marek Kulus, ProfMD, Mohamed H Shamji, ProfMD, Louis-Philippe Boulet, ProfMD, Matteo Bonini, MD, Luisa Brussino, MD, G Walter Canonica, ProfMD, Alvaro A Cruz, MD, Bilun Gemicioglu, ProfMD, Tari Haahtela, ProfMD, Maciej Kupczyk, MD, Violeta Kvedariene, MD, Desirée Larenas-Linnemann, MD, Renaud Louis, ProfMD, Marek Niedoszytko, ProfMD, Nhân Pham-Thi, MD, Francesca Puggioni, MD, Jan Romantowski, MD, Joaquin Sastre, ProfMD, Nicola Scichilone, ProfMD, Luis Taborda-Barata, ProfMD, Maria Teresa Ventura, MD, Rafael José Vieira, MD, Ioana Agache, ProfMD, Anna Bedbrook, BSc, Karl C Bergmann, MD, Rita Amaral, PhD, Luís Filipe Azevedo, PhD, Sinthia Bosnic-Anticevich, ProfPhD, Guy Brusselle, ProfMD, Roland Buhl, ProfMD, Lorenzo Cecchi, MD, Denis Charpin, MD, Claudia Chaves Loureiro, MD, Frédéric de Blay, ProfMD, Stefano Del Giacco, ProfMD, Philippe Devillier, ProfMD, Ewa Jassem, ProfMD, Guy Joos, ProfMD, Marek Jutel, ProfMD, Ludger Klimek, MD, Piotr Kuna, ProfMD, Daniel Laune, PhD, Jorge Luna Pech, MD, Mika Makela, ProfMD, Mario Morais-Almeida, MD, Rachel Nadif, PhD, Hugo E Neffen, MD, Ken Ohta, ProfMD, Nikolaos G Papadopoulos, ProfMD, Alberto Papi, ProfMD, Benoit Pétré, MD, Oliver Pfaar, MD, Daniela Rivero Yeverino, MD, Carlos Robalo Cordeiro, ProfMD, Nicolas Roche, ProfMD, Ana Sá-Sousa, PhD, Boleslaw Samolinski, ProfMD, Aziz Sheikh, ProfMD, Charlotte Suppli Ulrik, ProfMD, Omar S Usmani, ProfMD, Arunas Valiulis, ProfMD, Olivier Vandenplas, ProfMD, Pedro Vieira-Marques, PhD, Arzu Yorgancioglu, ProfMD, Torsten Zuberbier, ProfMD, Josep M Anto, ProfMD, João A Fonseca, PhD, Jean Bousquet, ProfMD
Publikováno v:
The Lancet: Digital Health, Vol 5, Iss 4, Pp e227-e238 (2023)
Summary: Background: Validated questionnaires are used to assess asthma control over the past 1–4 weeks from reporting. However, they do not adequately capture asthma control in patients with fluctuating symptoms. Using the Mobile Airways Sentinel
Externí odkaz:
https://doaj.org/article/56dce9f1f5fa4cbca1e55bfb1691b095